Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BRMS1 reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. Additionally we are shipping BRMS1 Proteins (9) and BRMS1 Kits (5) and many more products for this protein.
Showing 10 out of 61 products:
Human Monoclonal BRMS1 Primary Antibody for IP, ELISA - ABIN565191
Liu, Smith, Jones: Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. in Molecular and cellular biology 2006
Show all 8 references for ABIN565191
Human Monoclonal BRMS1 Primary Antibody for ELISA, WB - ABIN393891
Wu, McEwen, Harihar, Baker, DeWald, Zhou: BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study. in Cancer letters 2010
Show all 5 references for ABIN393891
Human Monoclonal BRMS1 Primary Antibody for WB - ABIN393598
Frolova, Edmonds, Bodenstine, Seitz, Johnson, Feng, Welch, Frost: A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. in Tumour biology 2009
Show all 5 references for ABIN393598
Human Polyclonal BRMS1 Primary Antibody for WB - ABIN1881120
Vaidya, Sanchez, Kim, Welch: Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells. in Cancer letters 2009
Show all 4 references for ABIN1881120
Aberrant methylation of BRMS1 frequently occurs in the down-regulation of BRMS1 in triple negative breast cancer and that it may play a role in the metastasis of breast cancer.
the present study demonstrates a mechanical cascade of BRMS1 suppressing cancer cell invasion through downregulating HIF-1alpha (show HIF1A Antibodies) transcript and consequently reducing Snail (show SNAI1 Antibodies) and TWIST1 (show TWIST1 Antibodies) expression.
MRTF-A (show MKL1 Antibodies) and STAT3 (show STAT3 Antibodies) synergistically recruited DNMT1 (show DNMT1 Antibodies) to hypermethylate the promoter of BRMS1 and affect the expression of BRMS1.MRTF-A (show MKL1 Antibodies) and STAT3 (show STAT3 Antibodies) promote breast cancer cell migration via hypermethylating BRSM1.
BRMS1 expression in human breast cancer is negatively correlated with JARID1C (show KDM5C Antibodies) expression. Our results, for the first time, portray a pivotal role of JARID1C (show KDM5C Antibodies) in regulating metastatic behaviors of breast cancer cells
loss of BRMS1 promotes malignant phenotypes that are dependent on NF-kappaB (show NFKB1 Antibodies)-dependent regulation of Twist1 (show TWIST1 Antibodies)
BRMS1 is a key regulator required to maintain a cellular morphology and cytoskeletal architecture consistent with an epithelial phenotype.
BRMS1 overexpression inhibited glioma cell invasion.
BRMS1-expressing cells remained rounded.
Silencing of BRMS 1 significantly induced the expression of NF-kappaB (show NFKB1 Antibodies) subunit, p65 (show GORASP1 Antibodies), uPA (show PRAP1 Antibodies), and OPN (show SPP1 Antibodies) proteins
Methylation of BRMS1 promoter in cfDNA isolated from plasma of NSCLC patients provides important prognostic information and merits to be further evaluated as a circulating tumour biomarker.
findings indicate the expression of Brms1L (show BRMS1L Antibodies) depends on beta-catenin (show CTNNB1 Antibodies) activity and contributes to follicle stimulating hormone beta (show FSHB Antibodies) induction by Gonadotropin-Releasing Hormone.
The Brms1 suppressed pulmonary metastasis and promoted apoptosis of tumor cells located in the lungs but not in the mammary glands.
BRMS1 may participate in transcriptional regulation via interaction with the mSin3.HDAC (show HDAC3 Antibodies) complex
results show for the first time that BRMS1 contains both nuclear import and export signals enabling its nucleo-cytoplasmic shuttling
This gene reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. The protein encoded by this gene localizes primarily to the nucleus and is a component of the mSin3a family of histone deacetylase complexes (HDAC). The protein contains two coiled-coil motifs and several imperfect leucine zipper motifs. Alternative splicing results in two transcript variants encoding different isoforms.
breast cancer metastasis suppressor 1
, breast cancer metastasis-suppressor 1
, breast cancer metastasis-suppressor 1 homolog
, breast cancer metastasis-suppressor 1-like protein